aod9604 vs semaglutide and AOD 9604 Peptide Therapy AOD 9604 Vs. Semaglutide: Applications,

Weight Loss and Fluid Shifts : GLP-1 medications typically produce significant weight loss, particularly in the initial months of treatment

Monitoring mental health during the transition to GLP-1 therapy is essential, and any significant mood changes should prompt immediate discussion with a healthcare provider

These may present as localised redness and swelling at the injection site or, less commonly, as widespread urticaria or angioedema

It is important to note that weight loss is more than just a number

SOURCES:

Hormonal and Signaling Changes In the normal growth cycle of hair follicles, hair growth is stimulated by a factor known as insulin-like growth factor 1 (IGF-1)